Singapore markets close in 3 hours 52 minutes
  • Straits Times Index

    3,110.33
    +39.17 (+1.28%)
     
  • Nikkei

    28,906.67
    +163.42 (+0.57%)
     
  • Hang Seng

    28,924.92
    +384.09 (+1.35%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • BTC-USD

    53,754.63
    +3,281.26 (+6.50%)
     
  • CMC Crypto 200

    1,085.65
    +61.44 (+6.00%)
     
  • S&P 500

    3,821.35
    -20.59 (-0.54%)
     
  • Dow

    31,802.44
    +306.14 (+0.97%)
     
  • Nasdaq

    12,609.16
    -310.99 (-2.41%)
     
  • Gold

    1,684.70
    +6.70 (+0.40%)
     
  • Crude Oil

    65.50
    +0.45 (+0.69%)
     
  • 10-Yr Bond

    1.5960
    +0.0420 (+2.70%)
     
  • FTSE Bursa Malaysia

    1,621.60
    +9.79 (+0.61%)
     
  • Jakarta Composite Index

    6,240.17
    -8.30 (-0.13%)
     
  • PSE Index

    6,766.83
    +9.91 (+0.15%)
     

Global Addisons Disease Therapeutics Market Research 2021-2025 | COVID-19 Industry Impact Analysis | Technavio

·4-min read

The Addisons disease therapeutics market is poised to grow by USD 247.90 million during 2021-2025 progressing at a CAGR of almost 5% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210122005160/en/

Technavio has announced its latest market research report titled Global Addisons Disease Therapeutics Market 2021-2025 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the Addisons disease therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designations.

The Addisons disease therapeutics market analysis includes the therapy segment and geography landscape. This study identifies the expanding research into the development of regenerative therapy as one of the prime reasons driving the Addisons disease therapeutics market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The Addisons disease therapeutics market covers the following areas:

Addison's Disease Therapeutics Market Sizing

Addison's Disease Therapeutics Market Forecast

Addison's Disease Therapeutics Market Analysis

Companies Mentioned

  • Actiza Pharmaceutical Pvt. Ltd.

  • Akorn Inc.

  • Amneal Pharmaceuticals Inc.

  • Bristol-Myers Squibb Co.

  • Diurnal Group Plc

  • Hikma Pharmaceuticals Plc

  • Merck & Co. Inc.

  • Novartis AG

  • Pfizer Inc.

  • Takeda Pharmaceutical Co. Ltd.

Related Reports on Health Care Include:

Global Critical Care Therapeutics Market- The critical care therapeutics market is segmented by drug class (albumin, antithrombin concentrates, prothrombin complex concentrates, factor XIII concentrates, and fibrinogen concentrates), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report

Global Parkinson's Disease (PD) Drugs Market- The Parkinson's disease (PD) drugs market is segmented by drug class (DA and levodopa-carbidopa, MAO inhibitors, AChE inhibitors, glutamate inhibitors, and others), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2020

  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five Forces Summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Therapy

  • Market segments

  • Comparison by Therapy

  • Oral drugs - Market size and forecast 2020-2025

  • Parenteral drugs - Market size and forecast 2020-2025

  • Market opportunity by Therapy

  • COVID-19 impact and recovery for Therapy segment

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2020-2025

  • Europe - Market size and forecast 2020-2025

  • Asia - Market size and forecast 2020-2025

  • ROW - Market size and forecast 2020-2025

  • Key leading countries

  • Market opportunity by geography

  • Volume drivers – Demand led growth

  • Market challenges

  • Market trends

Vendor Landscape

  • Overview

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Actiza Pharmaceutical Pvt. Ltd.

  • Akorn Inc.

  • Amneal Pharmaceuticals Inc.

  • Bristol-Myers Squibb Co.

  • Diurnal Group Plc

  • Hikma Pharmaceuticals Plc

  • Merck & Co. Inc.

  • Novartis AG

  • Pfizer Inc.

  • Takeda Pharmaceutical Co. Ltd.

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005160/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/